SAB Biotherapeutics Inc. (SABS) Statistics & Valuation Metrics - Stocknear

SAB Biotherapeutics Inc.

NASDAQ: SABS · Real-Time Price · USD
2.28
0.02 (0.88%)
At close: Sep 05, 2025, 3:59 PM
2.19
-3.91%
After-hours: Sep 05, 2025, 06:11 PM EDT

SAB Biotherapeutics Statistics

Share Statistics

SAB Biotherapeutics has 10.41M shares outstanding. The number of shares has increased by 0.68% in one year.

10.41M
0.68%
0.68%
23.78%
8.39M
393
0.03%

Short Selling Information

The latest short interest is 501.96K, so 5.4% of the outstanding shares have been sold short.

501.96K
5.4%
6.83%
3.84

Valuation Ratios

The PE ratio is -1.03 and the forward PE ratio is -1.93. SAB Biotherapeutics's PEG ratio is 0.02.

-1.03
-1.93
26.55
59.3
1.35
-1.01
0.02
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for SAB Biotherapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 2.98, with a Debt / Equity ratio of 0.18.

2.98
2.98
0.18
-0.16
-0.13
-134.77

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$20.98K
$-541.35K
63
0.03
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -19.72% in the last 52 weeks. The beta is 0.55, so SAB Biotherapeutics's price volatility has been higher than the market average.

0.55
-19.72%
2.25
2.29
53.95
1,432,779

Income Statement

In the last 12 months, SAB Biotherapeutics had revenue of 1.32M and earned -34.1M in profits. Earnings per share was -3.68.

1.32M
-3.47M
-42.91M
-34.1M
-28.99M
-33.79M
-3.68
Full Income Statement

Balance Sheet

The company has 8.9M in cash and 4.67M in debt, giving a net cash position of 4.23M.

8.9M
4.67M
4.23M
-124.17M
30.13M
-1.37M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -34.29M and capital expenditures -337.26K, giving a free cash flow of -34.63M.

-34.29M
-337.26K
-34.63M
-3.74
Full Cash Flow Statement

Margins

Gross margin is -262.48%, with operating and profit margins of -3245.92% and -2579.8%.

-262.48%
-3245.92%
-2579.8%
-2579.8%
-2193.19%
-3245.92%
-2619.46%

Dividends & Yields

SABS does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for SABS is $11.5, which is 404.4% higher than the current price. The consensus rating is "Buy".

$11.5
404.4%
Buy
4
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Jan 5, 2024. It was a backward split with a ratio of 1:10.

Jan 5, 2024
backward
1:10

Scores

-9.85
1